NCT05154968View on ClinicalTrials.gov

A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

December 14, 2021

Study Completion Date

December 14, 2021

Conditions

Healthy Participants

Interventions

DRUG

Sodium chloride

Administered SC infusion.

DRUG

Citrate buffer

Administered SC infusion.

DRUG

Mannitol

Administered SC infusion.

DEVICE

Prefilled Autoinjector

Used to administer the drug through SC infusion.

Trial Locations (1)

G1P 0A2

Syneos Health, Québec

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT05154968 - A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants | Biotech Hunter | Biotech Hunter